Literature DB >> 11825619

Native-like secondary structure of molten globules.

Konstantin S Vassilenko1, Vladimir N Uversky.   

Abstract

The most common evidence for the existence of secondary structure in a globular protein is the presence of a strongly pronounced far-UV circular dichroism (CD) spectrum. Although CD spectra of native proteins are well described and their quantitative analysis is widely used, similar studies for denatured proteins have still to be done. Far-UV CD spectra of nine proteins in the native and the pH-induced molten globule states were acquired and analyzed. Singular value decomposition showed that the spectra of molten globules could be described as a superposition of at least three independent components (most likely alpha-, beta- and irregular structure). A self-consistent procedure of CD spectra analysis revealed the existence of a clear correlation between the shape of the molten globule spectra and the content of secondary structure elements in the corresponding native proteins, as determined from X-ray data. A mathematical expression of this correlation in terms of the Pierson coefficient amounts to the value of 0.9 for both the alpha-helix and the beta-structure. Thus, the secondary structure of proteins in the molten globule state is close to that in the native state.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11825619     DOI: 10.1016/s0167-4838(01)00303-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  Temperature- and pH-induced multiple partially unfolded states of recombinant human interferon-alpha2a: possible implications in protein stability.

Authors:  Vikas K Sharma; Devendra S Kalonia
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

Review 2.  Understanding protein non-folding.

Authors:  Vladimir N Uversky; A Keith Dunker
Journal:  Biochim Biophys Acta       Date:  2010-02-01

Review 3.  A look back at the molten globule state of proteins: thermodynamic aspects.

Authors:  Eva Judy; Nand Kishore
Journal:  Biophys Rev       Date:  2019-05-04

4.  The Cytoplasm-Entry Domain of Antibacterial CdiA Is a Dynamic α-Helical Bundle with Disulfide-Dependent Structural Features.

Authors:  Nicholas L Bartelli; Sheng Sun; Grant C Gucinski; Hongjun Zhou; Kiho Song; Christopher S Hayes; Frederick W Dahlquist
Journal:  J Mol Biol       Date:  2019-06-08       Impact factor: 5.469

5.  Stability, denaturation and refolding of Mycobacterium tuberculosis MfpA, a DNA mimicking protein that confers antibiotic resistance.

Authors:  Sergei Khrapunov; Michael Brenowitz
Journal:  Biophys Chem       Date:  2011-05-05       Impact factor: 2.352

6.  Comparison of guanidine hydrochloride (GdnHCl) and urea denaturation on inactivation and unfolding of human placental cystatin (HPC).

Authors:  Fouzia Rashid; Sandeep Sharma; Bilqees Bano
Journal:  Protein J       Date:  2005-07       Impact factor: 2.371

7.  Membrane-induced changes in the holomyoglobin tertiary structure: interplay with function.

Authors:  Liana V Basova; Elisaveta I Tiktopulo; Victor P Kutyshenko; Stanislav I Klenin; Vitalii A Balobanov; Valentina E Bychkova
Journal:  Eur Biophys J       Date:  2014-05-11       Impact factor: 1.733

8.  Secondary-structure analysis of denatured proteins by vacuum-ultraviolet circular dichroism spectroscopy.

Authors:  Koichi Matsuo; Yoshie Sakurada; Ryuta Yonehara; Mikio Kataoka; Kunihiko Gekko
Journal:  Biophys J       Date:  2007-03-16       Impact factor: 4.033

9.  A molten globule intermediate of the von Willebrand factor A1 domain firmly tethers platelets under shear flow.

Authors:  Alexander Tischer; Pranathi Madde; Luis M Blancas-Mejia; Matthew Auton
Journal:  Proteins       Date:  2013-11-22

10.  The p53 core domain is a molten globule at low pH: functional implications of a partially unfolded structure.

Authors:  Ana Paula D Ano Bom; Monica S Freitas; Flavia S Moreira; Danielly Ferraz; Daniel Sanches; Andre M O Gomes; Ana Paula Valente; Yraima Cordeiro; Jerson L Silva
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.